| # | Drug | Count |
|---|---|---|
| 0 | PANCRELIPASE | 28 |
| 1 | ADALIMUMAB | 15 |
| 2 | OMEPRAZOLE MAGNESIUM | 13 |
| 3 | OMEPRAZOLE | 12 |
| 4 | METFORMIN | 11 |
| 5 | GABAPENTIN | 8 |
| 6 | INSULIN GLARGINE | 8 |
| 7 | METFORMIN ER 500 MG | 8 |
| 8 | METFORMIN ER 750 MG | 8 |
| 9 | MORPHINE SULFATE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERTUGLIFLOZIN AND SITAGLIPTIN | 2 | 0.0167 |
| 1 | DESIPRAMINE HYDROCHLORIDE | 1 | 0.0036 |
| 2 | SODIUM MONOFLUOROPHOSPHATE | 1 | 0.0027 |
| 3 | ERTUGLIFLOZIN | 2 | 0.0018 |
| 4 | FERROUS ASPARTO GLYCINATE, IRON, ASCORBIC ACID, FOLIC ACID, CYANOCOBALAMIN, ZINC, AND SUCCINIC ACID | 1 | 0.0016 |
| 5 | AVALGLUCOSIDASE ALFA-NGPT | 1 | 0.0010 |
| 6 | EPINASTINE HYDROCHLORIDE | 1 | 0.0009 |
| 7 | IBUPROFEN, PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0008 |
| 8 | IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0008 |
| 9 | PANCRELIPASE | 28 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| 1 | Proton Pump Inhibitor [EPC] | 15 |
| 2 | Benzodiazepine [EPC] | 13 |
| 3 | GLP-1 Receptor Agonist [EPC] | 13 |
| 4 | Insulin Analog [EPC] | 12 |
| 5 | Osmotic Laxative [EPC] | 7 |
| 6 | Corticosteroid [EPC] | 6 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 6 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 6 |
| 9 | Serotonin-3 Receptor Antagonist [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 1 | Hedgehog Pathway Inhibitor [EPC] | 4 | 0.0004 |
| 2 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 4 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 5 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 6 | Barbiturate [EPC] | 2 | 0.0002 |
| 7 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 9 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |